Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Clinical outcomes of splenectomy in children: report of the splenectomy in congenital hemolytic anemia registry.

Rice HE, Englum BR, Rothman J, Leonard S, Reiter A, Thornburg C, Brindle M, Wright N, Heeney MM, Smithers C, Brown RL, Kalfa T, Langer JC, Cada M, Oldham KT, Scott JP, St Peter S, Sharma M, Davidoff AM, Nottage K, Bernabe K, Wilson DB, Dutta S, Glader B, Crary SE, Dassinger MS, Dunbar L, Islam S, Kumar M, Rescorla F, Bruch S, Campbell A, Austin M, Sidonio R, Blakely ML; Splenectomy in Congenital Hemolytic Anemia (SICHA) Consortium.

Am J Hematol. 2015 Mar;90(3):187-92. doi: 10.1002/ajh.23888. Epub 2014 Nov 24.

PMID:
25382665
2.

Prominent forehead hematomas ("goose-eggs") as an initial manifestation of hemophilia.

Plummer ES, Crary SE, Buchanan GR.

J Pediatr. 2013 Dec;163(6):1781-3. doi: 10.1016/j.jpeds.2013.07.012. Epub 2013 Aug 20.

PMID:
23968747
3.

Many disease-associated variants of hTERT retain high telomerase enzymatic activity.

Zaug AJ, Crary SM, Jesse Fioravanti M, Campbell K, Cech TR.

Nucleic Acids Res. 2013 Oct;41(19):8969-78. doi: 10.1093/nar/gkt653. Epub 2013 Jul 30.

4.

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.

Plummer ES, Crary SE, McCavit TL, Buchanan GR.

Pediatr Blood Cancer. 2013 Nov;60(11):1747-52. doi: 10.1002/pbc.24676. Epub 2013 Jul 6.

PMID:
23832487
5.

Splenectomy in children with "mild" hereditary spherocytosis.

Roy SM, Buchanan GR, Crary SE.

J Pediatr Hematol Oncol. 2013 Aug;35(6):430-3. doi: 10.1097/MPH.0b013e31829f3460.

PMID:
23823113
6.

Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN).

Abshire TC, Federici AB, Alvárez MT, Bowen J, Carcao MD, Cox Gill J, Key NS, Kouides PA, Kurnik K, Lail AE, Leebeek FW, Makris M, Mannucci PM, Winikoff R, Berntorp E; VWD PN.

Haemophilia. 2013 Jan;19(1):76-81. doi: 10.1111/j.1365-2516.2012.02916.x. Epub 2012 Jul 23.

PMID:
22823000
7.

Comparative effectiveness of different types of splenectomy for children with congenital hemolytic anemias.

Rice HE, Crary SE, Langer JC, Kemper AR; Splenectomy in Congenital Hemolytic Anemia Consortium.

J Pediatr. 2012 Apr;160(4):684-689.e13. doi: 10.1016/j.jpeds.2011.09.030. Epub 2011 Nov 3. Review.

PMID:
22050869
8.

Prevalence of pulmonary hypertension in hereditary spherocytosis.

Crary SE, Ramaciotti C, Buchanan GR.

Am J Hematol. 2011 Dec;86(12):E73-6. doi: 10.1002/ajh.22182. Epub 2011 Sep 26.

PMID:
21953840
9.

Hemolytic non-uremic syndrome.

Chen KS, Neunert CE, Crary SE, Buchanan GR.

Pediatr Blood Cancer. 2012 Jul 15;59(1):167-9. doi: 10.1002/pbc.23264. Epub 2011 Aug 1.

PMID:
21809436
10.

Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells.

Batista LF, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, Crary SM, Choi J, Sebastiano V, Cherry A, Giri N, Wernig M, Alter BP, Cech TR, Savage SA, Reijo Pera RA, Artandi SE.

Nature. 2011 May 22;474(7351):399-402. doi: 10.1038/nature10084.

11.

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy.

Crary SE, Hall K, Buchanan GR.

Pediatr Blood Cancer. 2011 Apr;56(4):615-9. doi: 10.1002/pbc.22930. Epub 2010 Dec 22. Erratum in: Pediatr Blood Cancer. 2012 Apr;58(4):655.

12.

Traditional laboratory measures of cardiovascular risk in hereditary spherocytosis.

Crary SE, Troendle S, Ahmad N, Buchanan GR.

Pediatr Blood Cancer. 2010 Oct;55(4):684-9. doi: 10.1002/pbc.22640.

13.

Vascular complications after splenectomy for hematologic disorders.

Crary SE, Buchanan GR.

Blood. 2009 Oct 1;114(14):2861-8. doi: 10.1182/blood-2009-04-210112. Epub 2009 Jul 27. Review.

14.

Postsplenectomy vascular complications: Feasibility of studying patients with splenectomy following trauma.

Purcell PL, Crary SE, Adix LM, Alder AC, Buchanan GR.

Am J Hematol. 2009 May;84(5):316-7. doi: 10.1002/ajh.21389. No abstract available.

PMID:
19338046
15.

Experience with intravenous enoxaparin in critically ill infants and children.

Crary SE, Van Orden H, Journeycake JM.

Pediatr Crit Care Med. 2008 Nov;9(6):647-9. doi: 10.1097/PCC.0b013e31818d1920.

PMID:
18838932
16.

Laboratory markers of thrombosis risk in children with hereditary spherocytosis.

Troendle SB, Adix L, Crary SE, Buchanan GR.

Pediatr Blood Cancer. 2007 Nov;49(6):781-5.

PMID:
17854065
17.

Determination of pediatric norms for assessment of upper venous system post-thrombotic syndrome.

Boulden BM, Crary SE, Buchanan GR, Journeycake JM.

J Thromb Haemost. 2007 May;5(5):1077-9. No abstract available.

PMID:
17459008
18.

The 2'-O-methyltransferase responsible for modification of yeast tRNA at position 4.

Wilkinson ML, Crary SM, Jackman JE, Grayhack EJ, Phizicky EM.

RNA. 2007 Mar;13(3):404-13. Epub 2007 Jan 22.

19.

Venous thrombosis and thromboembolism in children with osteomyelitis.

Crary SE, Buchanan GR, Drake CE, Journeycake JM.

J Pediatr. 2006 Oct;149(4):537-41.

PMID:
17011328
20.

Fatal central venous catheter-related infection in haemophilia.

Crary SE, Buchanan GR, Journeycake JM.

Haemophilia. 2006 Mar;12(2):183-6.

PMID:
16476095
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk